Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Storme Moore-Thornicroft | F | - |
Emergex Vaccines Holding Ltd.
Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | 8 anni |
Thomas Rademacher | M | - |
Emergex Vaccines Holding Ltd.
Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | 8 anni |
Finian Tan | M | - |
Emergex Vaccines Holding Ltd.
Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Ramila Philip | M | - |
ImmProNano, Inc.
ImmProNano, Inc. BiotechnologyHealth Technology ImmProNano, Inc. engages in cell based immunological assays, proteomic analysis and services, and nanotechnology applications and consultation solutions. The company was founded by Mohan Philip, Ramila Philip, Xiaofang Huang, and Aykan Karabudak and is headquartered in Doylestown, PA. | - |
Xiaofang Huang | M | - |
ImmProNano, Inc.
ImmProNano, Inc. BiotechnologyHealth Technology ImmProNano, Inc. engages in cell based immunological assays, proteomic analysis and services, and nanotechnology applications and consultation solutions. The company was founded by Mohan Philip, Ramila Philip, Xiaofang Huang, and Aykan Karabudak and is headquartered in Doylestown, PA. | - |
Aykan Karabudak | M | - |
ImmProNano, Inc.
ImmProNano, Inc. BiotechnologyHealth Technology ImmProNano, Inc. engages in cell based immunological assays, proteomic analysis and services, and nanotechnology applications and consultation solutions. The company was founded by Mohan Philip, Ramila Philip, Xiaofang Huang, and Aykan Karabudak and is headquartered in Doylestown, PA. | - |
Michael D. Vaughan Rake | M | 76 |
Emergex Vaccines Holding Ltd.
Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | 1 anni |
Sergio Pagani | M | - |
Emergex Vaccines Holding Ltd.
Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Yi Xiang Dong | M | - |
Emergex Vaccines Holding Ltd.
Emergex Vaccines Holding Ltd. Pharmaceuticals: MajorHealth Technology Emergex Vaccines Holding Ltd. is a biotechnology company, which engages in the development of medicines against viral and bacterial infectious diseases. It focuses on the vaccines for dengue fever, Zika, Ebola, pandemic flu, and serious intra-cellular bacterial infections. The company was founded by Storme Moore-Thornicroft and Thomas Rademacher in 2016 and is headquartered in Abingdon, the United Kingdom. | - |
Grafico relazionale
Relazione in diverse aziende
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 6 | 66.67% |
Stati Uniti | 3 | 33.33% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Mohan Philip
- Contatti personali